Bioiberica signs agreement for distribution in South Korea
The distribution of Bioiberica's Palbio™ range through Mill Tech Co., Inc. in South Korea has been approved after fulfilling stringent regulatory requirements.
Bioiberica signed a strategic agreement with Mill Tech Co., Inc. for the exclusive distribution of its hydrolyzed protein range for animal nutrition, Palbio™, in South Korea. The agreement comes after the successful fulfillment of rigorous export requirements to the country, enabled by Bioiberica’s robust production process, which ensures the biosecurity of its entire animal nutrition portfolio. This move marks a milestone in the companies’ long-standing strategic partnership, solidifying their collective offering in South Korea. The companies have been working together for several years to distribute Bioiberica’s Nucleoforce™ range, used to support the immunological and intestinal health of farm animals and aquaculture species.
Palbio™ 50 RD is now authorized for distribution in more than 40 countries, including the recent addition of South Korea. It is a safe source of high-quality hydrolyzed proteins in the form of L-α-amino acids and bioactive peptides. Palbio™ 50 RD has been shown to positively affect the intestinal health of young animals, improving digestion and feed intake to ensure productivity improvements in pig, poultry and fish. In addition, Palbio™ 50 RD is highly palatable and easily digested by all farm animal species and manufactured via innovative and strictly controlled processes to meet regulatory requirements for the use of animal proteins in feed to protect public health.
“A strategic market for Bioiberica, South Korea has some of the highest regulatory standards for animal nutrition products. As such, only the highest quality products are eligible for sale in the country,” said Joan Bassa, business units director of Heparin Science, Animal Nutrition and Plant Health at Bioiberica. “Thanks to our commitment to quality and transparency, alongside Mill Tech Co., Inc’s collaboration in this complex process, we have been able to successfully evidence Palbio’s™ compliance to launch these highly effective raw materials in South Korea. The success of our partnership further highlights the critical importance of collaboration in bringing products to new markets, and we look forward to continuing to grow our business and expertise together.”